1,174
edits
ACST-1: Difference between revisions
Jump to navigation
Jump to search
→Subgroup Analysis
Tag: visualeditor |
Tag: visualeditor |
||
| Line 120: | Line 120: | ||
===Subgroup Analysis<!-- Was there a subgroup analysis? If so, include a summary of it here. -->=== | ===Subgroup Analysis<!-- Was there a subgroup analysis? If so, include a summary of it here. -->=== | ||
* At 10-years, | * At 10-years, there was no significant heterogeneity between benefits in subgroups of age, gender, pre-randomisation cholesterol, pre-randomisation systolic blood pressure, severity of stenosis, diabetes mellitus, IHD, use of anti-hypertensive, anti-thrombotic or lipid-lowering agents at entry. | ||
* However subgroup analyses are not definitive due to the small number of events.<!-- Were there significant adverse events recorded other than those listed in the secondary outcomes? If so, list them here --> | * At 10-years, there was no significant heterogeneity between perioperative hazards in subgroups of age, gender or severity of stenosis. | ||
* However subgroup analyses are not definitive due to the small number of events in the trial.<!-- Were there significant adverse events recorded other than those listed in the secondary outcomes? If so, list them here --> | |||
==Criticisms== | ==Criticisms== | ||